Log In
BCIQ
Print this Print this
 

VS-4718

  Manage Alerts
Collapse Summary General Information
Company Verastem Inc.
DescriptionInhibitor of focal adhesion kinase (FAK) targeting cancer stem cells
Molecular Target Focal adhesion kinase (FAK)
Mechanism of ActionFocal adhesion kinase (FAK) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$1.4M

$1.4M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/03/2014

$1.4M

$1.4M

0

Get a free BioCentury trial today